Targeting SARS-CoV-2 papain-like protease in the postvaccine era

While vaccines remain at the forefront of global healthcare responses, pioneering therapeutics against SARS-CoV-2 are expected to fill the gaps for waning immunity. Rapid development and approval of orally available direct-acting antivirals targeting crucial SARS-CoV-2 proteins marked the beginning...

Descripción completa

Detalles Bibliográficos
Autores principales: Ton, Anh-Tien, Pandey, Mohit, Smith, Jason R., Ban, Fuqiang, Fernandez, Michael, Cherkasov, Artem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399131/
https://www.ncbi.nlm.nih.gov/pubmed/36114026
http://dx.doi.org/10.1016/j.tips.2022.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399131/
https://www.ncbi.nlm.nih.gov/pubmed/36114026
http://dx.doi.org/10.1016/j.tips.2022.08.008

Ejemplares similares